Douwe F. Postma
-
- Nosocomial Infections in ICU 7
- Epidemiology top 5%
- Pneumonia and Respiratory Infections 16
- Pneumocystis jirovecii pneumonia detection and treatment 7
- Sepsis Diagnosis and Treatment 4
- Emergency Medicine top 5%
- Emergency and Acute Care Studies 7
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 5
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Co-authors
- Cornelis H. van WerkhovenJan Jelrik OosterheertMarc J. M. BontenAndy I. M. HoepelmanLeontine J. R. van EldenSteven ThijsenJan M. PrinsWim Boersma
- Cited by
- Applied Microbiology and BiotechnologyCritical Care and Intensive Care MedicineEpidemiology
- Journals
- New England Journal of Medicine (2 papers)PLoS ONE (1 paper)Clinical Infectious Diseases (1 paper)
- Partner nations
- NetherlandsUnited StatesColombia
In The Last Decade
Douwe F. Postma
34 papers receiving 715 citations
Peers
Comparison fields: 5 of 82
- Applied Microbiology and Biotechnology 71
- Critical Care and Intensive Care Medicine 108
- Epidemiology 488
- Emergency Medicine 101
- Infectious Diseases 182
Countries citing papers authored by Douwe F. Postma
This map shows the geographic impact of Douwe F. Postma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douwe F. Postma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douwe F. Postma more than expected).
Fields of papers citing papers by Douwe F. Postma
This network shows the impact of papers produced by Douwe F. Postma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douwe F. Postma. The network helps show where Douwe F. Postma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Douwe F. Postma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 15 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 7 | |
| 10 | 2021 | 5 | |
| 11 | 2020 | 27 | |
| 12 | 2018 | 6 | |
| 13 | 2017 | 6 | |
| 14 | 2017 | 4 | |
| 15 | 2017 | 2 | |
| 16 | 2015 | 103 | |
| 17 | 2014 | 1 | |
| 18 | 2013 | 23 | |
| 19 | 2012 | 2 | |
| 20 | 2012 | 51 |
About Douwe F. Postma
Douwe F. Postma is a scholar working on Critical Care and Intensive Care Medicine, Applied Microbiology and Biotechnology and Epidemiology, having authored 37 papers that have together received 733 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (16 papers), Emergency and Acute Care Studies (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), Nosocomial Infections in ICU (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (5 papers), Sepsis Diagnosis and Treatment (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (71 citations), Critical Care and Intensive Care Medicine (108 citations) and Epidemiology (488 citations). Douwe F. Postma has collaborated with scholars based in Netherlands, United States and Colombia. Frequent co-authors include Cornelis H. van Werkhoven, Jan Jelrik Oosterheert, Marc J. M. Bonten, Andy I. M. Hoepelman, Leontine J. R. van Elden, Steven Thijsen, Jan M. Prins, Wim Boersma, Jan Kluytmans and Susanne M. Huijts. Their work appears in journals such as New England Journal of Medicine, PLoS ONE and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.